BCMA-Targeted Prime CAR-T Cell Therapy

BCMA-targeted prime CAR-T cell therapy · Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA-Targeted Prime CAR-T Cell Therapy, covering 2025-02-25 to 2025-02-25. Get the full timeline:

Most recent: Clinical Trial Update: a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease [Phase 1, Phase 2]

See pricing